| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/06/2007 | US20070207204 Dosage Form for Time-Varying Patterns of Drug Delivery |
| 09/06/2007 | US20070207202 Pharmaceutical formulations of a monohydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 09/06/2007 | US20070207201 Liquid and Semi-Solid Pharmaceutical Formulations and Processes |
| 09/06/2007 | US20070207198 Use Of N-Acety1-D-Glucosamine In The Manufacture Of Medicaments For Anti-Tumors And Anti-Metastasis |
| 09/06/2007 | US20070207196 Tocopherol-modified therapeutic drug compound formulations |
| 09/06/2007 | US20070207193 aersols, creams, lotions |
| 09/06/2007 | US20070207191 Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
| 09/06/2007 | US20070207183 Zein coated medical device |
| 09/06/2007 | US20070207179 Medical Device |
| 09/06/2007 | US20070207175 Biaromatic compound activators of PPARgamma receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 09/06/2007 | US20070207173 Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| 09/06/2007 | US20070207172 Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus |
| 09/06/2007 | US20070207161 Immunomodulating Compositions and uses Therefor |
| 09/06/2007 | US20070207149 Cancer treatment using viruses and camptothecins |
| 09/06/2007 | US20070207148 Genes associated with obesity and methods for using the same |
| 09/06/2007 | US20070207144 Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy |
| 09/06/2007 | US20070207140 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 09/06/2007 | US20070207138 S/O Type Pharmaceutical Preparation and Method for Producing the Same |
| 09/06/2007 | US20070207137 Inhibition of Jun Kinase |
| 09/06/2007 | US20070207136 Food and vitamin preparations containing the natural isomer of reduced folates |
| 09/06/2007 | US20070207132 Synbiotic Composition For Infants |
| 09/06/2007 | US20070207122 Compositons and methods of use of ritonavir for treating hcv |
| 09/06/2007 | US20070207121 Methods of Using and Compositions Comprising Selective Cytokine Inhibitory Drugs for Treatment and Management of Macular Degeneration |
| 09/06/2007 | US20070207120 Selective Killing Of Cancer Cells By Induction Of Acetyltransferase Via Tnf-Alpha And Il-6 |
| 09/06/2007 | US20070207119 synergistic; Tumor necrosis factor related apoptosis inducing ligand and LAQ824 (N-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]prop-2-enamide) Dacinostat, which augments Apo-2L/TRAIL-induced DISC (death inducing signaling complex) and apoptosis of human acute leukemia cells |
| 09/06/2007 | US20070207117 For use on the skin includes a carbomer, a starch, vitamins, moisturizers, an astringent, a Pluronic, dimethicone, and an aluminum compound (aluminum acetate); compatible with the use of gloves, including latex gloves |
| 09/06/2007 | US20070207116 Antioxidant compositions for the eye |
| 09/06/2007 | US20070207115 Tea Tree Oil and Benzoyl Peroxide Acne Treatment |
| 09/06/2007 | US20070207112 Anti-acne composition |
| 09/06/2007 | US20070207108 Processes for Producing Cellooligosaccharide |
| 09/06/2007 | US20070207105 Anti-microbial compositions |
| 09/06/2007 | US20070207094 Hardenable thermally responsive compositions |
| 09/06/2007 | US20070207091 Nebulizer Formulation |
| 09/06/2007 | US20070207089 Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent |
| 09/06/2007 | US20070207088 Anti-Inflammatory Analgesic Adhesive Patch |
| 09/06/2007 | DE202007001889U1 Oral zu verabreichende Zusammensetzung zur Prävention und/oder Behandlung der Sonnenallergie und/oder des Sonnenbrandes Orally administrable composition for the prevention and / or treatment of sun allergies and / or sunburn |
| 09/06/2007 | DE202007000129U1 Zusammensetzung aus marinen Sedimenten und Polysacchariden auf Chitinbasis zur Behandlung der Hautoberfläche Composition of marine sediments and polysaccharides chitin for the treatment of the skin surface |
| 09/06/2007 | DE10262018B4 Zusammensetzungen, Nahrungs-, Lebens-, und Genussmittel, Süßwaren, Tierfuttermittel, diätische Spezial-Ernährung, Kinderernährung, Süßungsmittel und pharmazeutische Zusammensetzungen enthaltend kondensierte Palatinose Compositions, food, food and beverage, confectionery, pet food, dietary special diet, child nutrition, sweeteners and pharmaceutical compositions containing condensed palatinose |
| 09/06/2007 | DE102006009928A1 Substituierte Arylsulfonamide Substituted aryl sulfonamides |
| 09/06/2007 | DE102006009889A1 Topical product, useful for the prevention of eye irritation, and for prevention and treatment of blepharitis, comprises cobalamin in the form of cyano-, hydroxy- and/or methyl-cobalamin |
| 09/06/2007 | DE102006009888A1 Topisches Produkt gegen Windeldermatitis, neuronale Störungen und Hyperammonämie The topical product for diaper rash, neural disorders and hyperammonemia |
| 09/06/2007 | DE102006009850A1 Verwendung von Glycyrrhetinsäure und/oder Glycyrrhizin zur Herstellung kosmetischer Zubereitungen zur Bräunung der Haut Use of glycyrrhetinic acid and / or glycyrrhizin for producing cosmetic preparations for skin tanning |
| 09/06/2007 | DE102006009813A1 Verwendung von A2b/A1 Rezeptor Agonisten zur Modulation der Lipidspiegel Use of A2b / A1 receptor agonists to modulate lipid levels |
| 09/06/2007 | DE102006008880A1 Aminopyrimidinderivate Aminopyrimidine derivatives |
| 09/06/2007 | DE102005018641B4 Verwendung von Verbindungen zur Prophylaxe und / oder Behandlung von Tumoren Use of compounds for the prophylaxis and / or treatment of tumors |
| 09/06/2007 | DE102004008375B4 Verwendung von physiologisch verträglichen Ascorbatverbindungen in Kombination mit einem Sympathomimetikum als lokales Therapeutikum für Schleimhäute der Atemwege Use of physiologically acceptable ascorbate in combination with a sympathomimetic agent as a local therapy for respiratory mucous membranes |
| 09/05/2007 | EP1830191A2 Pharmaceutical preparations containing thiazolidinediones showing new therapeutic indications |
| 09/05/2007 | EP1829887A1 Cpg single-strand deoxynucleotides for use as adjuvant |
| 09/05/2007 | EP1829885A1 Modified 5'- phosphonate azidothymidine-potential anti-viral preparations |
| 09/05/2007 | EP1829882A2 Epimers and isomers of tetrazole containing rapamycin analogs, methods of making and using the same |
| 09/05/2007 | EP1829881A1 Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same |
| 09/05/2007 | EP1829880A2 Derivatives of camptothecin for use in treating cancer |
| 09/05/2007 | EP1829878A1 New morphine derivatives and pharmaceutical compositions containing the same |
| 09/05/2007 | EP1829877A1 Bicyclic pyrrole derivatives |
| 09/05/2007 | EP1829876A1 Nitrogeneous tricyclic compound |
| 09/05/2007 | EP1829875A1 Pyrazole derivatives as sigma receptor inhibitors |
| 09/05/2007 | EP1829874A1 Tricyclic compound and use thereof |
| 09/05/2007 | EP1829873A1 Pyrrazole derivatives as sigma receptors antagonists |
| 09/05/2007 | EP1829869A1 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
| 09/05/2007 | EP1829867A1 Imidazole compounds having pharmaceutical activity towards the sigma receptor |
| 09/05/2007 | EP1829866A1 Sigma receptor inhibitors |
| 09/05/2007 | EP1829864A1 Isoquinoline derivatives as calpain inhibitors |
| 09/05/2007 | EP1829863A1 Arylalkanoic acid derivative |
| 09/05/2007 | EP1829862A1 Sigma receptor compounds |
| 09/05/2007 | EP1829861A2 Pyrrolidine ester derivatives active as oxytocin antagonists |
| 09/05/2007 | EP1829860A1 9,10-secopregnane derivative and medicine |
| 09/05/2007 | EP1829858A2 Dibenzylamine compounds and pharmaceutical use thereof |
| 09/05/2007 | EP1829856A2 Transfection reagents |
| 09/05/2007 | EP1829550A2 Methods for treating an ischemic disorder and improving stroke outcome |
| 09/05/2007 | EP1829547A2 Treatment of neurodegenerative disease through intracranial delivery of short interfering RNA (siRNA) |
| 09/05/2007 | EP1829546A1 Formulations containing tetracyclines for treating or preventing mucositis |
| 09/05/2007 | EP1829545A1 Prostaglandin f2 alpha derivative containing products |
| 09/05/2007 | EP1829544A1 Pharmaceutically active morpholinol |
| 09/05/2007 | EP1829543A1 Preventive agent/remedial agent for constipation predominant IBS |
| 09/05/2007 | EP1829542A1 Peroxisome proliferator-activated receptor (ppar) activator and drug, supplement, functional food and food additive using the same |
| 09/05/2007 | EP1829541A1 Formulation comprising fenofibric acid or a physiologically acceptable salt thereof |
| 09/05/2007 | EP1829540A1 Preventive/therapeutic composition for liver disease |
| 09/05/2007 | EP1829539A2 A method for treating tension-type headache |
| 09/05/2007 | EP1829538A1 Solid preparation comprising reduced coenzyme q10 and process for production of the same |
| 09/05/2007 | EP1829537A1 Composition for body fat reduction |
| 09/05/2007 | EP1829536A1 Ameliorant for renal insufficiency |
| 09/05/2007 | EP1829535A2 Tissue factor antagonists and methods of use thereof |
| 09/05/2007 | EP1829534A1 Use of compounds binding to the sigma receptor for the treatment of metabolic syndrome |
| 09/05/2007 | EP1829533A2 Pharmaceutical formulations for dry powder inhalers |
| 09/05/2007 | EP1829530A2 Stabilisation of active agents by formulation into nanoparticulate form |
| 09/05/2007 | EP1829529A1 Controlled release compositions of estradiol metabolites |
| 09/05/2007 | EP1829528A2 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 09/05/2007 | EP1829527A2 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 09/05/2007 | EP1829525A1 Composition and method for accelerating fibulin-5 production and/or enhancing fibulin-5 activity |
| 09/05/2007 | EP1829523A1 Cosmetic use of an N-oxide derivative of theophylline |
| 09/05/2007 | EP1828415A1 Method of inhibiting expression of target mrna using sirna consisting of nucleotide sequence complementary to said target mrna |
| 09/05/2007 | EP1828389A1 Sparc promoter mutations associated with drug resistance, and methods, oligonucleotides, cells and arrays associated therewith |
| 09/05/2007 | EP1828249A2 Biomarkers for pre-selection of patients for anti-igf1r therapy |
| 09/05/2007 | EP1828223A2 Novel betulin derivatives, preparation thereof and use thereof |
| 09/05/2007 | EP1828222A1 Process for the preparation of drospirenone |
| 09/05/2007 | EP1828221A1 Pure rocuronium bromide |
| 09/05/2007 | EP1828216A2 Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 09/05/2007 | EP1828215A2 Oligonucleotides comprising a modified or non-natural nucleobase |
| 09/05/2007 | EP1828209A2 Sulfonamido-macrocycles as tie2 inhibitors |
| 09/05/2007 | EP1828207A1 Thiazolopyridinone derivates as mch receptor antagonists |